# Fairfax Cryobank Inc - Fairfax – FDA Inspection, Mar 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/fairfax-cryobank-inc-fairfax/9bf7a477-56a9-4aa2-8e4d-0438a705ba56
Source feed: FDA_Inspections

> FDA inspection 1083931 of Fairfax Cryobank Inc - Fairfax, March 20, 2019. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 1271. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1083931
- Company Name: Fairfax Cryobank Inc - Fairfax
- Inspection Date: 2019-03-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1268297 - 2025-04-24
- [FDA Inspection 1216117 - 2023-08-24](https://www.keypedia.com/records/fda_inspections/fairfax-cryobank-inc-fairfax/7782913d-2553-4fca-9b67-1596763408c0)
- FDA Inspection 996121 - 2016-12-01
- FDA Inspection 798105 - 2012-08-28

## Related Officers

- [Company Rep](https://www.keypedia.com/people/shavon-l-square/6a15df34-1af6-44f7-8874-c8606691f7e0)

Company: https://www.keypedia.com/companies/fairfax-cryobank-inc-fairfax/ce331f0e-c4b9-40b8-9182-1709e5126e9f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
